pharma · Gastroesophageal Reflux · Migraine · ADXN
Addex Therapeutics
Addex Therapeutics is a pharma organization headquartered in GENEVA, V8, CH. It trades on NYSE under ticker ADXN. Primary therapeutic focus areas include Gastroesophageal Reflux, Migraine, Parkinson's Disease, Blepharosp
GENEVA, V8, CH HQ
2002 Founded
21 Employees
Public company Type
ADXN · NYSE Ticker
Company details
- Status
- Public
- HQ
- GENEVA, V8, CH
- Founded
- 2002
- Employees
- 21
- Programs
- 6
- Drugs
- 3
- Patents
- 40
Dipraglurant
Phase 3 · small molecule · Parkinson Disease
Dipraglurant for Parkinson Disease is a Phase 3 program (small_molecule) at Addex Therapeutics with 2 ClinicalTrials.gov record(s).
Internal code ADX48621-301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Addex Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Parkinson Disease
- Status
- terminated
- Trials
- 2